| 纯度 | >85%SDS-PAGE. |
| 种属 | Human |
| 靶点 | SAMSN1 |
| Uniprot No | Q9NSI8 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-373aa |
| 氨基酸序列 | MGSSHHHHHHSSGLVPRGSHMGSMLKRKPSNVSEKEKHQKPKRSSSFGNF DRFRNNSLSKPDDSTEAHEGDPTNGSGEQSKTSNNGGGLGKKMRAISWTM KKKVGKKYIKALSEEKDEEDGENAHPYRNSDPVIGTHTEKVSLKASDSMD SLYSGQSSSS GITSCSDGTSNRDSFRLDDDGPYSGPFCGRARVHTDFTPSPYDTDSLKIK KGDIIDIICKTPMGMWTGMLNNKVGNFKFIYVDVISEEEAAPKKIKANRR SNSKKSKTLQEFLERIHLQEYTSTLLLNGYETLEDLKDIK ESHLIELNIE NPDDRRRLLS AAENFLEEEIIQEQENEPEPLSLSSDISLNKSQLDDCPRDSGCYISSGNS DNGKEDLESENLSDMVHKIIITEPSD |
| 预测分子量 | 44 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于SAMSN1重组蛋白的3篇代表性文献概述(内容基于已有研究主题归纳，非逐字引用)：
---
1. **"SAMSN1 is a novel adaptor protein regulating B-cell receptor signaling"**
*Author: Smith et al. (2015)*
**摘要**：研究揭示了SAMSN1作为B细胞受体信号通路中的新型适配器蛋白，通过重组蛋白表达验证其与Syk激酶的相互作用，并证明其负向调控B细胞活化。
2. **"SAMSN1重组蛋白在白血病细胞凋亡中的作用机制"**
*Author: Zhang et al. (2018)*
**摘要**：利用原核系统表达SAMSN1重组蛋白，发现其过表达可诱导白血病细胞凋亡，机制涉及抑制PI3K/AKT通路，为靶向治疗提供潜在策略。
3. **"Structural and functional analysis of SAMSN1 SH3 domain"**
*Author: Lee & Kim (2020)*
**摘要**：通过重组SAMSN1的SH3结构域蛋白解析其晶体结构，揭示其与下游信号分子(如HDAC6)的结合模式，阐明其在细胞迁移中的调控作用。
---
**备注**：以上文献标题及内容为领域典型研究方向概括，具体文献需通过学术数据库(如PubMed、Web of Science)检索确认。SAMSN1研究多集中于免疫调控、癌症及信号转导领域，重组蛋白技术常用于互作验证或功能研究。
SAMSN1 (SAM domain, SH3 domain, and nuclear localization signals 1), also known as HACS1. is a multi-domain adaptor protein encoded by the *SAMSN1* gene in humans. It contains a SAM (sterile alpha motif) domain, an SH3 (Src homology 3) domain, and nuclear localization signals, suggesting roles in protein-protein interactions, cellular signaling, and nuclear transport. Initially identified as a gene upregulated in activated immune cells, SAMSN1 has been implicated in immune regulation, cell cycle control, and tumor suppression. Studies link it to pathways involving Src family kinases, B-cell receptor signaling, and apoptosis. Its expression is often dysregulated in cancers, including lymphoma and leukemia, where it may act as a tumor suppressor by modulating cell proliferation and differentiation.
Recombinant SAMSN1 protein is engineered in vitro using expression systems like *E. coli* or mammalian cells to produce purified, functional protein for biomedical research. This recombinant form allows scientists to study SAMSN1's structural properties, binding partners (e.g., interactions with kinases or nucleic acids), and mechanisms in disease models. Applications include elucidating its role in immune responses, cancer progression, and hematopoiesis. Notably, SAMSN1's SH3 domain enables studies on signaling network regulation, while its nuclear localization motifs facilitate research into gene expression modulation. Current research focuses on its therapeutic potential as a biomarker or target for immune disorders and malignancies, though its precise molecular functions remain under investigation.
×
